{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:18:26Z","timestamp":1774084706446,"version":"3.50.1"},"reference-count":13,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[1998,7,1]],"date-time":"1998-07-01T00:00:00Z","timestamp":899251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1998,7]]},"abstract":"ABSTRACT<\/jats:title>\n \n The in vivo antibacterial activities of a new oral trinem, sanfetrinem cilexetil (a prodrug of sanfetrinem), were evaluated in comparison with those of cefdinir and amoxicillin. Sanfetrinem cilexetil showed potent efficacy against experimental murine septicemia caused by\n Staphylococcus aureus<\/jats:italic>\n ,\n Streptococcus pyogenes<\/jats:italic>\n , and\n Escherichia coli<\/jats:italic>\n and against murine respiratory infections caused by\n Streptococcus pneumoniae<\/jats:italic>\n . Likewise, in murine models of respiratory infection by penicillin-susceptible and penicillin-resistant\n S. pneumoniae<\/jats:italic>\n , sanfetrinem cilexetil was more effective than amoxicillin in reducing the number of bacteria in infected lungs. These results were reflected in its potent in vitro activity and high levels in plasma.\n <\/jats:p>","DOI":"10.1128\/aac.42.7.1858","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:33:03Z","timestamp":1539045183000},"page":"1858-1861","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["In Vivo Antibacterial Activities of Sanfetrinem Cilexetil, a New Oral Tricyclic Antibiotic"],"prefix":"10.1128","volume":"42","author":[{"given":"Shinobu","family":"Tamura","sequence":"first","affiliation":[{"name":"Department of Microbiology, Toho University School of Medicine, Tokyo 143, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Toho University School of Medicine, Tokyo 143, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tateda","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Toho University School of Medicine, Tokyo 143, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Toho University School of Medicine, Tokyo 143, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Toho University School of Medicine, Tokyo 143, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Toho University School of Medicine, Tokyo 143, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Furuya","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Toho University School of Medicine, Tokyo 143, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Toho University School of Medicine, Tokyo 143, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/15.1.77"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2362"},{"key":"e_1_3_2_4_2","first-page":"102","article-title":"Method for the determination of minimum inhibitory concentration (MIC) of aerobic bacteria by microdilution.","volume":"38","author":"Japanese Society for Chemotherapy","year":"1990","unstructured":"Japanese Society for Chemotherapy Method for the determination of minimum inhibitory concentration (MIC) of aerobic bacteria by microdilution. Chemotherapy (Tokyo) 38 1990 102 105","journal-title":"Chemotherapy (Tokyo)"},{"key":"e_1_3_2_5_2","first-page":"183","article-title":"Method for the determination of minimum inhibitory concentration (MIC) of fastidious and anaerobic bacteria by microdilution.","volume":"41","author":"Japanese Society for Chemotherapy","year":"1993","unstructured":"Japanese Society for Chemotherapy Method for the determination of minimum inhibitory concentration (MIC) of fastidious and anaerobic bacteria by microdilution. Chemotherapy (Tokyo) 41 1993 183 189","journal-title":"Chemotherapy (Tokyo)"},{"key":"e_1_3_2_6_2","first-page":"1446","article-title":"Treatment of lower respiratory infections.","author":"McNamara J. T.","year":"1987","unstructured":"McNamara J. T. Treatment of lower respiratory infections. Lancet ii 1987 1446 1449","journal-title":"Lancet"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02355195","article-title":"Therapeutic efficacies of penicillin G, cefotaxime, and imipenem\/cilastatin against penicillin-resistant pneumococcal pneumonia in CBA\/J mice.","volume":"2","author":"Miyazaki H.","year":"1996","unstructured":"Miyazaki H. Tateda K. Matsumoto T. Miyazaki S. Yamaguchi K. Therapeutic efficacies of penicillin G, cefotaxime, and imipenem\/cilastatin against penicillin-resistant pneumococcal pneumonia in CBA\/J mice. J. Infect. Chemother. 2 1996 34 39","journal-title":"J. Infect. Chemother."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.9.1953"},{"key":"e_1_3_2_9_2","unstructured":"Perboni\n A.\n Tamborini\n B.\n Rossi\n T.\n Donati\n D.\n Gaviraghi\n G.\n Tribactams: a novel class of \u03b2-lactams\n Recent advances in antiinfective chemistry.\n Bentley\n P.\n Ponsford\n R.\n 1992\n 21\n 33\n Royal Society of Chemistry\n London England"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.9.2142"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.1.148"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-45-5-319"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.6.1520"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.5.1248"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.7.1858","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.42.7.1858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:08:37Z","timestamp":1645459717000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.42.7.1858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["10.1128\/AAC.42.7.1858"],"URL":"https:\/\/doi.org\/10.1128\/aac.42.7.1858","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]},"assertion":[{"value":"1997-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-05-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}